Coloplast to issue notes for EUR 3.5bn

The medtech firm has announced that it is establishing a program to sell senior unsecured notes for up to EUR 3.5bn, aiming to finance the acquisition of Atos Medical.
Photo: Coloplast / PR
Photo: Coloplast / PR
by ulrich quistgaard, translated by daniel pedersen

Coloplast is on the hunt for capital, and has prepared for this by establishing a Euro Medium Term Note (EMTN) program, the company has announced in a notification.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading